reboxetine has been researched along with cocaine in 10 studies
| Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (cocaine) | Trials (cocaine) | Recent Studies (post-2010) (cocaine) |
|---|---|---|---|---|---|
| 626 | 193 | 184 | 32,461 | 1,096 | 9,400 |
| Protein | Taxonomy | reboxetine (IC50) | cocaine (IC50) |
|---|---|---|---|
| Amyloid-beta precursor protein | Homo sapiens (human) | 0.338 | |
| Fatty acid-binding protein, heart | Homo sapiens (human) | 0.367 | |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.0855 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 0.0855 | |
| D | Rattus norvegicus (Norway rat) | 5.7544 | |
| Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 5.7544 | |
| Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 5.7544 | |
| Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 5.7544 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 1.2861 | |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.4321 | |
| 5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 0.0855 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.5442 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.8885 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.3796 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 5.541 | |
| Sodium-dependent dopamine transporter | Mus musculus (house mouse) | 0.2 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 1.05 | |
| Transporter | Rattus norvegicus (Norway rat) | 3.2277 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Charney, DS | 1 |
| Carboni, E; Di Chiara, G; Giros, B; Nosten-Bertrand, M; Spielewoy, C; Vacca, C | 1 |
| Nedergaard, OA; Rasmussen, LE | 1 |
| di Giannantonio, M; Farina, B | 1 |
| Carson, RE; Ding, YS; Gallezot, JD; Henry, S; Labaree, D; Malison, RT; Nabulsi, N; Neumeister, A; Planeta-Wilson, B; Ropchan, J; Singhal, T; Williams, W | 1 |
| Choi, SH; Kang, S; Kim, HJ; Lee, MS; Shin, KH; Shin, SK | 1 |
| Fisar, Z; Hroudová, J; Raboch, J | 1 |
| Borgkvist, A; Feltmann, K; Lindskog, M; Malmlöf, T; Schilström, B | 1 |
| Conrad, KL; Davis, AR; Javitch, JA; Lindsley, CW; Matthies, HJ; Saleh, SA; Sen, N; Sheffler, DJ; Shields, AD; Silberman, Y; Winder, DG | 1 |
| DePoy, LM; Manvich, DF; Weinshenker, D | 1 |
1 review(s) available for reboxetine and cocaine
| Article | Year |
|---|---|
Monoamine dysfunction and the pathophysiology and treatment of depression.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Carrier Proteins; Catecholamines; Cocaine; Depressive Disorder; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Morpholines; Nerve Tissue Proteins; Neuropeptides; Norepinephrine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Tomography, Emission-Computed, Single-Photon; Tryptophan | 1998 |
9 other study(ies) available for reboxetine and cocaine
| Article | Year |
|---|---|
Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Carrier Proteins; Chromatography, High Pressure Liquid; Cocaine; Cocaine-Related Disorders; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Extracellular Space; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Microdialysis; Morpholines; Nerve Tissue Proteins; Nucleus Accumbens; Piperazines; Reboxetine; Reinforcement, Psychology | 2001 |
Effects of reboxetine on sympathetic neuroeffector transmission in rabbit carotid artery.
Topics: Animals; Bretylium Compounds; Carotid Arteries; Cocaine; Desipramine; Morpholines; Neuroeffector Junction; Norepinephrine; Pargyline; Potassium; Rabbits; Reboxetine; Sympathetic Nervous System; Tritium | 2003 |
Reboxetine in cocaine withdrawal treatment: a three cases report.
Topics: Adult; Antidepressive Agents; Cocaine; Humans; Male; Morpholines; Reboxetine; Substance Withdrawal Syndrome | 2003 |
PET imaging of the effects of age and cocaine on the norepinephrine transporter in the human brain using (S,S)-[(11)C]O-methylreboxetine and HRRT.
Topics: Adult; Aging; Brain; Cocaine; Cocaine-Related Disorders; Dopamine Uptake Inhibitors; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Morpholines; Norepinephrine Plasma Membrane Transport Proteins; Positron-Emission Tomography; Radiopharmaceuticals; Reboxetine | 2010 |
Effects of reboxetine and citalopram pretreatment on changes in cocaine and amphetamine regulated transcript (CART) expression in rat brain induced by the forced swimming test.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Amygdala; Animals; Behavior, Animal; Citalopram; Cocaine; Corticosterone; Dopamine Uptake Inhibitors; Locus Coeruleus; Male; Morpholines; Nerve Tissue Proteins; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Reboxetine; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Swimming | 2010 |
Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Topics: Affect; Amitriptyline; Animals; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Cerebral Cortex; Citalopram; Clorgyline; Cocaine; Cyclohexanols; Desipramine; Fluoxetine; Imipramine; In Vitro Techniques; Iproniazid; Lithium; Mianserin; Mirtazapine; Mitochondria; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morpholines; Olanzapine; Pargyline; Reboxetine; Swine; Thiazepines; Valproic Acid; Venlafaxine Hydrochloride | 2010 |
Dopamine in the hippocampus is cleared by the norepinephrine transporter.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic Uptake Inhibitors; Amphetamine; Animals; Cocaine; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Drug Administration Routes; Drug Interactions; Hippocampus; Idazoxan; Male; Microdialysis; Morpholines; Nomifensine; Norepinephrine Plasma Membrane Transport Proteins; Raclopride; Rats; Rats, Wistar; Reboxetine; Sodium Channel Blockers; Tetrodotoxin; Time Factors; Wakefulness | 2012 |
Yohimbine depresses excitatory transmission in BNST and impairs extinction of cocaine place preference through orexin-dependent, norepinephrine-independent processes.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Behavior, Animal; Cocaine; Drug-Seeking Behavior; Extinction, Psychological; Intracellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Neuropeptides; Neurotransmitter Agents; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Orexin Receptors; Orexins; Patch-Clamp Techniques; Reboxetine; Receptors, Adrenergic, alpha-2; Receptors, Corticotropin-Releasing Hormone; Receptors, Neuropeptide; Reward; Septal Nuclei; Synaptic Transmission; Yohimbine | 2012 |
Dopamine β-hydroxylase inhibitors enhance the discriminative stimulus effects of cocaine in rats.
Topics: Adrenergic Uptake Inhibitors; Animals; Cocaine; Conditioning, Operant; Discrimination Learning; Discrimination, Psychological; Disulfiram; Dopamine beta-Hydroxylase; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Imidazoles; Male; Morpholines; Rats; Rats, Sprague-Dawley; Reboxetine; Thiones | 2013 |